Palladyne AI lands exclusive US rights to build IAI's Harpy and Harop loitering munitions
Palladyne AI signed an MoU for up-to-10-year exclusive US rights to make and market IAI's combat-proven Harpy, Harop and Mini-Harpy loitering munitions, onshoring them as the Pentagon scales munition buys.
A Salt Lake City software firm just put combat-proven Israeli loitering munitions on a US production line, betting on a Pentagon that is buying the category fast.
Palladyne AI (NASDAQ: PDYN) disclosed the memorandum of understanding in a June 8 8-K, saying it now holds the exclusive US right to manufacture and market IAI's Harpy, Harop and Mini-Harpy loitering munitions to the US government. The cooperation can run as long as ten years if milestones are met, according to the filing.
Most of the cost falls on Palladyne. It has to stand up a US assembly line on its own dime and pay IAI a market-rate royalty on sales, with nothing due upfront, the 8-K shows. IAI licenses the underlying intellectual property and may supply key subsystems. The arrangement is still only an MoU rather than a definitive contract, and it does not stop Israel from selling the systems to Washington directly.
Harpy is the reason the deal matters. The munition loiters for hours, then dives on an air-defense radar in the seconds an operator switches it on, Breaking Defense reported, putting the warhead above 30 pounds on a design fielded since the 1980s. Palladyne plans to Americanize the airframes and add its SwarmOS autonomy software, CEO Ben Wolff told the outlet.
The first contract in its sights is the Army's Long-Range Precision Munition competition this fall, which wants a 100km-plus weapon against integrated air defenses, Defense Daily noted. Wolff told Breaking Defense the notice points to a prototype agreement worth $100 million to $200 million in October, and he counts at least five funded programs worth chasing inside a year.
The battlefield and the startup story — free in your inbox every week. No paywall.
Subscribe Free →That is the onshoring bet. Pentagon loitering-munition budgets are rising, IAI said, and Palladyne is wagering that a combat-proven Israeli airframe built in America, with a US autonomy layer, fields faster than a clean-sheet design. IAI already builds hardware stateside through Stark Aerospace in Mississippi. Whether the October prototype call turns the MoU into money is the next thing to watch.
Frequently Asked Questions
What did Palladyne AI and IAI agree to?
Palladyne AI signed a memorandum of understanding giving it the exclusive US right to manufacture and market IAI's Harpy, Harop and Mini-Harpy loitering munitions to the US government, according to the company's June 8 8-K filing.
How long does the deal last?
The cooperation under the MoU can run for up to ten years if certain milestones are met, with options to extend, move to non-exclusive terms or end it, per the 8-K. It is an MoU, not a definitive contract.
What is the Harpy and why does it matter?
Harpy is a long-range anti-radiation loitering munition that waits in the air for hours, then dives on enemy radar when it switches on, Breaking Defense reported. The Harpy/Harop family carries a warhead of more than 30 pounds and has been fielded since the 1980s.
What does Palladyne AI add to the Israeli systems?
Palladyne will adapt the airframes to US requirements and install its SwarmOS autonomy software, which lets the drones share sensor data with each other and with other platforms, CEO Ben Wolff told Breaking Defense.
Which US contract is the deal aimed at first?
The first target is the US Army's Long-Range Precision Munition competition this fall, which seeks a more than 100km capability against integrated air defenses, Defense Daily noted. Wolff told Breaking Defense the notice anticipates a prototype agreement worth $100 million to $200 million in October.
Does IAI already build anything in the US?
Yes. IAI's US presence includes growing local production through subsidiaries such as Stark Aerospace in Columbus, Mississippi, according to the companies' joint announcement.
AI-generated summary, reviewed by an editor. More on our AI guidelines.
